| pubmed-article:7808955 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7808955 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:7808955 | lifeskim:mentions | umls-concept:C0348890 | lld:lifeskim |
| pubmed-article:7808955 | lifeskim:mentions | umls-concept:C0010592 | lld:lifeskim |
| pubmed-article:7808955 | pubmed:issue | 12-13 | lld:pubmed |
| pubmed-article:7808955 | pubmed:dateCreated | 1995-1-31 | lld:pubmed |
| pubmed-article:7808955 | pubmed:abstractText | Five patients with aplastic anemia were treated with cyclosporine A. In four cases a positive response was noted. In three out of these patients frequency of blood transfusions was decreased. Platelet count increased to 50 x 10(9)/L in two cases and in one case agranulocytosis disappeared. Synergistic effect of cyclosporine A with oxymetholone and prednisone was seen. In one case an improvement lasted only for 1 year. Hepatotoxicity being a complication of therapy was noted in one patient. | lld:pubmed |
| pubmed-article:7808955 | pubmed:language | pol | lld:pubmed |
| pubmed-article:7808955 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7808955 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7808955 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7808955 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7808955 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7808955 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7808955 | pubmed:issn | 0032-3756 | lld:pubmed |
| pubmed-article:7808955 | pubmed:author | pubmed-author:KonopkaLL | lld:pubmed |
| pubmed-article:7808955 | pubmed:author | pubmed-author:MajSS | lld:pubmed |
| pubmed-article:7808955 | pubmed:author | pubmed-author:S?omkowskiMM | lld:pubmed |
| pubmed-article:7808955 | pubmed:author | pubmed-author:LORCHI JIJ | lld:pubmed |
| pubmed-article:7808955 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7808955 | pubmed:volume | 49 | lld:pubmed |
| pubmed-article:7808955 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7808955 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7808955 | pubmed:pagination | 289-90 | lld:pubmed |
| pubmed-article:7808955 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:7808955 | pubmed:meshHeading | pubmed-meshheading:7808955-... | lld:pubmed |
| pubmed-article:7808955 | pubmed:meshHeading | pubmed-meshheading:7808955-... | lld:pubmed |
| pubmed-article:7808955 | pubmed:meshHeading | pubmed-meshheading:7808955-... | lld:pubmed |
| pubmed-article:7808955 | pubmed:meshHeading | pubmed-meshheading:7808955-... | lld:pubmed |
| pubmed-article:7808955 | pubmed:meshHeading | pubmed-meshheading:7808955-... | lld:pubmed |
| pubmed-article:7808955 | pubmed:meshHeading | pubmed-meshheading:7808955-... | lld:pubmed |
| pubmed-article:7808955 | pubmed:meshHeading | pubmed-meshheading:7808955-... | lld:pubmed |
| pubmed-article:7808955 | pubmed:meshHeading | pubmed-meshheading:7808955-... | lld:pubmed |
| pubmed-article:7808955 | pubmed:meshHeading | pubmed-meshheading:7808955-... | lld:pubmed |
| pubmed-article:7808955 | pubmed:meshHeading | pubmed-meshheading:7808955-... | lld:pubmed |
| pubmed-article:7808955 | pubmed:meshHeading | pubmed-meshheading:7808955-... | lld:pubmed |
| pubmed-article:7808955 | pubmed:meshHeading | pubmed-meshheading:7808955-... | lld:pubmed |
| pubmed-article:7808955 | pubmed:meshHeading | pubmed-meshheading:7808955-... | lld:pubmed |
| pubmed-article:7808955 | pubmed:articleTitle | [Cyclosporin in the treatment of idiopathic aplastic anemia]. | lld:pubmed |
| pubmed-article:7808955 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7808955 | pubmed:publicationType | English Abstract | lld:pubmed |
